Literature DB >> 10545076

Comparison of the diagnostic accuracy of three commercially available enzyme immunoassays for anti-p53 antibodies.

J Rohayem1, K Conrad, T Zimmermann, K H Frank.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545076

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Rapid and Sensitive Detection of p53 Based on DNA-Protein Binding Interactions Using Silver Nanoparticle Films and Microwave Heating.

Authors:  Muzaffer Mohammed; Kadir Aslan
Journal:  Nano Biomed Eng       Date:  2014-11-10

Review 2.  Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.

Authors:  Aravind Suppiah; John Greenman
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

3.  p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer.

Authors:  Norman Häfner; Kristin Nicolaus; Stefanie Weiss; Manfred Frey; Herbert Diebolder; Matthias Rengsberger; Matthias Dürst; Ingo B Runnebaum
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-11       Impact factor: 4.553

4.  Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer.

Authors:  J W Pedersen; A Gentry-Maharaj; E-O Fourkala; A Dawnay; M Burnell; A Zaikin; A E Pedersen; I Jacobs; U Menon; H H Wandall
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

5.  Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.

Authors:  F D Vogl; M Frey; R Kreienberg; I B Runnebaum
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.